VitaNova Life Sciences Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 31, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Revenue	3.19	2.66	0.57	0.04	0.12	-
Revenue Growth (YoY)	154.79%	366.47%	1401.83%	-68.33%	-	-
Cost of Revenue	1.39	1.09	0.19	-	-	-
Gross Profit	1.8	1.58	0.38	0.04	0.12	-
Selling, General & Admin	0.61	0.37	0.17	0.06	0.13	0.05
Operating Expenses	0.61	0.37	0.17	0.06	0.13	0.05
Operating Income	1.2	1.21	0.21	-0.02	-0.01	-0.05
Interest Expense	-0	-0	-	-	-	-
Other Non Operating Income (Expenses)	0	0	0	-	-	-
EBT Excluding Unusual Items	1.19	1.2	0.21	-0.02	-0.01	-0.05
Other Unusual Items	-	-	-	-	0.15	-
Pretax Income	1.19	1.2	0.21	-0.02	0.14	-0.05
Income Tax Expense	0.45	0.35	0.06	-	-	-
Earnings From Continuing Operations	0.75	0.85	0.14	-0.02	0.14	-0.05
Net Income	0.75	0.85	0.14	-0.02	0.14	-0.05
Net Income to Common	0.75	0.85	0.14	-0.02	0.14	-0.05
Net Income Growth	241.44%	503.94%	-	-	-	-
Shares Outstanding (Basic)	8	8	4	2	2	2
Shares Outstanding (Diluted)	8	8	4	2	2	2
Shares Change (YoY)	135.00%	135.00%	81.28%	-	-	-
EPS (Basic)	0.09	0.10	0.04	-0.01	0.07	-0.03
EPS (Diluted)	0.09	0.10	0.04	-0.01	0.06	-0.03
EPS Growth	45.29%	157.00%	-	-	-	-
Free Cash Flow	0.87	0.19	-0.38	-0.02	0	-0.04
Free Cash Flow Per Share	0.10	0.02	-0.11	-0.01	0.00	-0.02
Gross Margin	56.46%	59.19%	66.19%	100.00%	100.00%	-
Operating Margin	37.44%	45.39%	36.03%	-63.75%	-11.14%	-
Profit Margin	23.34%	31.96%	24.68%	-63.75%	116.40%	-
Free Cash Flow Margin	27.09%	7.24%	-65.86%	-48.35%	3.38%	-
EBIT	1.2	1.21	0.21	-0.02	-0.01	-0.05
EBIT Margin	37.44%	45.39%	36.03%	-63.75%	-11.14%	-
Effective Tax Rate	37.58%	29.36%	31.53%	-	-	-